The main objective of the Investment approach is to generate capital appreciation through investments in equities with a medium to long-term perspective.
| Alpha (1Y) | Beta (1Y) | Standard Deviation (1Y) | % of +ve Months (SI) |
|---|---|---|---|
| -2.92% | 0.55 | 16.09% | 58.04% |
Performance Table #
| Trailing Returns (%) | 1m return | 3m return | 6m return | 1y return | 2y return | 3y return | 5y return | 10y return | Since inception return |
|---|---|---|---|---|---|---|---|---|---|
| Kotak Mahindra Asset Management Company Ltd Pharma and Healthcare | -5.50% | -14.00% | -10.65% | -5.65% | 4.58% | 16.05% | 11.72% | - | 11.45% |
| Nifty 50 TRI | -3.04% | -1.45% | 2.64% | 8.97% | 9.26% | 14.07% | 14.53% | 13.27% |
QRC Report Card *
| Strategy | Category | Fund Manager | Date of Inception | Age Of PMS | Corpus (in Cr, approx) | Benchmark | Returns SI (CAGR) | Stocks In Portfolio | Sectors In Portfolio |
|---|---|---|---|---|---|---|---|---|---|
| Kotak Mahindra Asset Management Company Ltd Pharma and Healthcare | Sector Fund | Mr. Brijesh Ved | 20 September 2016 | 9Y 4M | 20.26 | Nifty 50 TRI | 11.45% | - | 19 |
| Portfolio Quality (Q) | Portfolio Risk (R) | Portfolio Consistency (C) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Index | Category Alpha (1Y) | Relative Alpha (1Y) |
% of +ve Months
(Fund Data) |
Alpha (1Y) | Beta (1Y) |
Standard Deviation (1Y)
(Fund Data) |
Sharpe Ratio (1Y)
(Fund Data) |
Alpha (SI) | Information Ratio (SI) | Consistency Ratio % |
| Nifty 50 | -4.50% | -14.55% | 58.04% | -19.05% | 0.92 | 16.09% | -0.76 | -0.32% | -0.02 | 49.11 % |
| Nifty 500 | -0.68% | -14.55% | -15.23% | 0.89 | -1.08% | -0.07 | 49.11 % | |||
| Nifty Midcap 100 | 0.26% | -14.55% | -14.29% | 0.68 | -3.50% | -0.21 | 45.54 % | |||
| Nifty Smallcap 100 | 11.63% | -14.55% | -2.92% | 0.55 | 0.28% | 0.01 | 45.54 % | |||
VIEW DETAILED QUALITY, RISK, CONSISTENCY ANALYSIS
Portfolio Holdings
| Holding | % |
|---|
Sector Allocation
| Holding | % |
|---|---|
| PHARMA & BIOTECH | 5.62 |
| PHARMA & BIOTECH | 1.17 |
| PHARMA & BIOTECH | 16.46 |
| PHARMA & BIOTECH | 12.45 |
| HEALTHCARE SERVICES | 7.63 |
| PHARMA & BIOTECH | 2.99 |
| PHARMA & BIOTECH | 6.08 |
| HEALTHCARE SERVICES | 3.20 |
| PHARMA & BIOTECH | 5.71 |
| PHARMA & BIOTECH | 3.56 |
| HEALTHCARE SERVICES | 5.37 |
| PHARMA & BIOTECH | 3.80 |
| PHARMA & BIOTECH | 3.18 |
| PHARMA & BIOTECH | 6.08 |
| PHARMA & BIOTECH | 4.27 |
| PHARMA & BIOTECH | 1.69 |
| PHARMA & BIOTECH | 3.01 |
| PHARMA & BIOTECH | 3.93 |
| PHARMA & BIOTECH | 2.72 |
Market Cap Allocation
| Allocations | % |
|---|---|
| Large Cap | |
| Mid Cap | 24.06 |
| Small Cap | 75.62 |
| Cash | 0.32 |
Do Not Simply Invest, Make Informed Decisions
WISH TO MAKE INFORMED INVESTMENTS FOR LONG TERM WEALTH CREATION
Book
a call with our PMS AIF Specialists
Disclaimer
#Returns as of 31st Jan 2026. Returns up to 1 Year are absolute, above 1 Year are CAGR.
*QRC Report Card data is updated quarterly. Current data is as of Dec 25.
